Yunnan Chihong Zinc&Germanium Co Ltd (600497)
Shanghai Stock Exchange · China · prices in CNY · close of 19 Oct 2026
Key indicators
| Last close | CNY 7.920 |
|---|---|
| 52-week range | 5.843 – 13.500 |
| Return, 1 month / 3 months | −23.3% / −19.1% |
| Return, 1 year / 3 years | +34.6% / +57.9% |
| Trend | Below its 200-day average |
| RSI (14) | 27 |
| Volatility (1 year) | 57.8% |
| Worst drawdown (1 year) | -38.1% |
| Average daily value traded | 1,175.42M CNY |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Yunnan Chihong Zinc & Germanium is a Chinese nonferrous metals company based in Qujing, in Yunnan province. It mines and smelts zinc and lead ores and recovers germanium and other metals as by-products of its processing. Its customers are industrial users of refined metals, including manufacturers and processors in China and abroad. The company operates mining and smelting facilities in its home region and supplies metal products to domestic and export markets.
On this site Yunnan Chihong Zinc&Germanium Co Ltd appears as a stock on the Shanghai Stock Exchange (China), code 600497, with prices in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Yunnan Chihong Zinc&Germanium Co Ltd (600497) trades on the Shanghai Stock Exchange in China. It last closed at CNY 7.920 on 19 October 2026.
Its price-based Market X-Ray is 62 out of 100 (a fair price profile), ranking 597 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.6% and over the last three months it fell 19.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -15.0% | ||
| From 52-week high | -38.1% | ||
| Momentum | 63 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -19.1% | ||
| 6-month return | -3.1% | ||
| 12-month return, skipping the last month | 75.6% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 57.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.1% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 1,175.42M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | 64 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −7.5% |
|---|---|
| 1 month | −23.3% |
| 3 months | −19.1% |
| 6 months | −3.1% |
| 1 year | +34.6% |
| 3 years | +57.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 9.689 / 9.322 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.334 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 26 May 2026 | CNY 0.0700 |
| 11 Nov 2025 | CNY 0.0300 |
| 19 Jun 2025 | CNY 0.1300 |
| 21 Jun 2024 | CNY 0.1400 |
| 30 Jun 2023 | CNY 0.1200 |
| 8 Jul 2022 | CNY 0.1200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.